🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/07/1996 | 31,01 | 31,07 | 30,36 | 30,47 | -1,16% | 2,31% | 3.866.072 |
| 24/07/1996 | 29,82 | 30,89 | 29,70 | 30,83 | +1,57% | 4,00% | 7.178.171 |
| 23/07/1996 | 31,49 | 31,55 | 30,36 | 30,36 | -3,05% | 3,79% | 6.738.430 |
| 22/07/1996 | 30,83 | 31,31 | 30,83 | 31,31 | +1,55% | 1,55% | 6.685.402 |
| 19/07/1996 | 30,83 | 31,07 | 30,42 | 30,83 | +0,39% | 2,13% | 6.317.763 |
| 18/07/1996 | 30,12 | 30,89 | 29,82 | 30,71 | +2,59% | 3,56% | 5.800.680 |
| 17/07/1996 | 29,58 | 30,12 | 29,16 | 29,94 | +2,66% | 3,23% | 5.080.075 |
| 16/07/1996 | 29,58 | 29,64 | 27,79 | 29,16 | -1,81% | 6,25% | 11.953.698 |
| 15/07/1996 | 30,36 | 30,83 | 29,64 | 29,70 | -1,82% | 3,93% | 5.904.222 |
| 12/07/1996 | 30,53 | 30,53 | 29,94 | 30,25 | -1,12% | 1,95% | 4.378.963 |
| 11/07/1996 | 30,95 | 31,01 | 30,36 | 30,59 | -1,35% | 2,12% | 6.556.498 |
| 10/07/1996 | 30,89 | 31,07 | 30,59 | 31,01 | +0,58% | 1,54% | 5.099.987 |
| 09/07/1996 | 31,07 | 31,13 | 30,83 | 30,83 | -0,39% | 0,96% | 3.283.594 |
| 08/07/1996 | 30,53 | 30,95 | 30,47 | 30,95 | +0,78% | 1,56% | 4.685.398 |
| 05/07/1996 | 31,07 | 31,13 | 30,65 | 30,71 | -2,46% | 1,54% | 3.456.933 |
| 03/07/1996 | 31,61 | 31,91 | 31,49 | 31,49 | +0,00% | 1,32% | 4.734.026 |
| 02/07/1996 | 31,49 | 31,55 | 31,13 | 31,49 | -0,19% | 1,33% | 5.308.539 |
| 01/07/1996 | 31,19 | 31,55 | 31,07 | 31,55 | +2,32% | 1,53% | 4.590.659 |
| 28/06/1996 | 31,37 | 31,37 | 30,83 | 30,83 | -1,34% | 1,71% | 4.480.200 |
| 27/06/1996 | 31,07 | 31,37 | 30,89 | 31,25 | +0,77% | 1,54% | 3.008.808 |
| 26/06/1996 | 31,19 | 31,31 | 30,95 | 31,01 | +0,00% | 1,15% | 4.197.240 |
| 25/06/1996 | 30,77 | 31,07 | 30,71 | 31,01 | +1,36% | 1,16% | 3.509.333 |
| 24/06/1996 | 31,19 | 31,19 | 30,59 | 30,59 | -1,54% | 1,91% | 3.945.301 |
| 21/06/1996 | 31,13 | 31,19 | 30,89 | 31,07 | +0,19% | 0,96% | 7.850.149 |
| 20/06/1996 | 30,65 | 31,13 | 30,53 | 31,01 | +1,76% | 1,95% | 5.234.341 |
| 19/06/1996 | 30,36 | 30,65 | 30,24 | 30,47 | +0,59% | 1,38% | 3.159.510 |
| 18/06/1996 | 30,42 | 30,47 | 30,24 | 30,30 | -0,20% | 0,78% | 3.973.597 |
| 17/06/1996 | 30,65 | 30,71 | 30,36 | 30,36 | -0,59% | 1,17% | 3.128.490 |
| 14/06/1996 | 30,65 | 30,71 | 30,42 | 30,53 | -0,58% | 0,97% | 2.861.040 |
| 13/06/1996 | 30,36 | 30,83 | 30,18 | 30,71 | +0,98% | 2,16% | 3.734.653 |